Innovis Asset Management’s Bristol-Myers Squibb BMY Stock Holding History

Innovis Asset Management’s Portfolio BMY Stock Details BMY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	$305K	Buy	5,248 +90	+2%	+$5.51K	0.12%	105
2023 Q2	$330K	Sell	5,158 -52	-1%	-$3.49K	0.12%	107
2023 Q1	$361K	Buy	5,210 +37	+0.7%	+$2.61K	0.15%	97
2022 Q4	$372K	Buy	+5,173	New	+$390K	0.17%	83

Other funds holding BMY

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Innovis Asset Management's BMY Position: Q3 2023 in Review

Innovis Asset Management increased its Bristol-Myers Squibb (BMY) stake by 1.7% in Q3 2023, buying an estimated $5.51K and bringing the position to 5,248 shares worth $305K. The position accounts for 0.12% of the portfolio, ranked #105.

Innovis Asset Management first reported a position in BMY in Q4 2022 and has held it in 4 quarters since. The position peaked at $372K in Q4 2022. 2,388 funds tracked by Wall St. Rank hold BMY as of Q3 2023.

Innovis Asset Management held 5,248 shares of Bristol-Myers Squibb worth $305K as of Q3 2023.
Innovis Asset Management bought 90 Bristol-Myers Squibb shares in Q3 2023, an estimated $5.51K.
Bristol-Myers Squibb made up 0.12% of Innovis Asset Management's portfolio in Q3 2023, its #105 holding.
Innovis Asset Management first reported a position in Bristol-Myers Squibb in Q4 2022 and has held it in 4 quarters since.
Innovis Asset Management's Bristol-Myers Squibb position peaked at $372K in Q4 2022.
2,388 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q3 2023.

Based on Innovis Asset Management's 13F filing for Q3 2023, filed 9 Nov 2023.